As mentioned above, elevated nuclear presence of YAP and TAZ can often be observed in a variety of human malignancies, including liver, lung, breast, skin, colon, and ovarian cancer (Harvey et al., 2013; Johnson and Halder, 2014; Piccolo et al., 2013). Here, YAP1 is linked to ovarian cancer.